Cargando…

Posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed Alzheimer's disease

Medial temporal lobe atrophy (MTA) is a recognized marker of Alzheimer's disease (AD), however, it can be prominent in frontotemporal lobar degeneration (FTLD). There is an increasing awareness that posterior atrophy (PA) is important in AD and may aid the differentiation of AD from FTLD. Visua...

Descripción completa

Detalles Bibliográficos
Autores principales: Lehmann, Manja, Koedam, Esther L.G.E., Barnes, Josephine, Bartlett, Jonathan W., Ryan, Natalie S., Pijnenburg, Yolande A.L., Barkhof, Frederik, Wattjes, Mike P., Scheltens, Philip, Fox, Nick C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3657170/
https://www.ncbi.nlm.nih.gov/pubmed/21596458
http://dx.doi.org/10.1016/j.neurobiolaging.2011.04.003
_version_ 1782270104771231744
author Lehmann, Manja
Koedam, Esther L.G.E.
Barnes, Josephine
Bartlett, Jonathan W.
Ryan, Natalie S.
Pijnenburg, Yolande A.L.
Barkhof, Frederik
Wattjes, Mike P.
Scheltens, Philip
Fox, Nick C.
author_facet Lehmann, Manja
Koedam, Esther L.G.E.
Barnes, Josephine
Bartlett, Jonathan W.
Ryan, Natalie S.
Pijnenburg, Yolande A.L.
Barkhof, Frederik
Wattjes, Mike P.
Scheltens, Philip
Fox, Nick C.
author_sort Lehmann, Manja
collection PubMed
description Medial temporal lobe atrophy (MTA) is a recognized marker of Alzheimer's disease (AD), however, it can be prominent in frontotemporal lobar degeneration (FTLD). There is an increasing awareness that posterior atrophy (PA) is important in AD and may aid the differentiation of AD from FTLD. Visual rating scales are a convenient way of assessing atrophy in a clinical setting. In this study, 2 visual rating scales measuring MTA and PA were used to compare atrophy patterns in 62 pathologically-confirmed AD and 40 FTLD patients. Anatomical correspondence of MTA and PA was assessed using manually-delineated regions of the hippocampus and posterior cingulate gyrus, respectively. Both MTA and PA scales showed good inter- and intrarater reliabilities (kappa > 0.8). MTA scores showed a good correspondence with manual hippocampal volumes. Thirty percent of the AD patients showed PA in the absence of MTA. Adding the PA to the MTA scale improved discrimination of AD from FTLD, and early-onset AD from normal aging. These results underline the importance of considering PA in AD diagnosis, particularly in younger patients where medial temporal atrophy may be less conspicuous.
format Online
Article
Text
id pubmed-3657170
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-36571702013-05-18 Posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed Alzheimer's disease Lehmann, Manja Koedam, Esther L.G.E. Barnes, Josephine Bartlett, Jonathan W. Ryan, Natalie S. Pijnenburg, Yolande A.L. Barkhof, Frederik Wattjes, Mike P. Scheltens, Philip Fox, Nick C. Neurobiol Aging Abstract of Online Article Medial temporal lobe atrophy (MTA) is a recognized marker of Alzheimer's disease (AD), however, it can be prominent in frontotemporal lobar degeneration (FTLD). There is an increasing awareness that posterior atrophy (PA) is important in AD and may aid the differentiation of AD from FTLD. Visual rating scales are a convenient way of assessing atrophy in a clinical setting. In this study, 2 visual rating scales measuring MTA and PA were used to compare atrophy patterns in 62 pathologically-confirmed AD and 40 FTLD patients. Anatomical correspondence of MTA and PA was assessed using manually-delineated regions of the hippocampus and posterior cingulate gyrus, respectively. Both MTA and PA scales showed good inter- and intrarater reliabilities (kappa > 0.8). MTA scores showed a good correspondence with manual hippocampal volumes. Thirty percent of the AD patients showed PA in the absence of MTA. Adding the PA to the MTA scale improved discrimination of AD from FTLD, and early-onset AD from normal aging. These results underline the importance of considering PA in AD diagnosis, particularly in younger patients where medial temporal atrophy may be less conspicuous. Elsevier 2012-03 /pmc/articles/PMC3657170/ /pubmed/21596458 http://dx.doi.org/10.1016/j.neurobiolaging.2011.04.003 Text en © 2012 Elsevier Inc. https://creativecommons.org/licenses/by/3.0/ Open Access under CC BY 3.0 (https://creativecommons.org/licenses/by/3.0/) license
spellingShingle Abstract of Online Article
Lehmann, Manja
Koedam, Esther L.G.E.
Barnes, Josephine
Bartlett, Jonathan W.
Ryan, Natalie S.
Pijnenburg, Yolande A.L.
Barkhof, Frederik
Wattjes, Mike P.
Scheltens, Philip
Fox, Nick C.
Posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed Alzheimer's disease
title Posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed Alzheimer's disease
title_full Posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed Alzheimer's disease
title_fullStr Posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed Alzheimer's disease
title_full_unstemmed Posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed Alzheimer's disease
title_short Posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed Alzheimer's disease
title_sort posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed alzheimer's disease
topic Abstract of Online Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3657170/
https://www.ncbi.nlm.nih.gov/pubmed/21596458
http://dx.doi.org/10.1016/j.neurobiolaging.2011.04.003
work_keys_str_mv AT lehmannmanja posteriorcerebralatrophyintheabsenceofmedialtemporallobeatrophyinpathologicallyconfirmedalzheimersdisease
AT koedamestherlge posteriorcerebralatrophyintheabsenceofmedialtemporallobeatrophyinpathologicallyconfirmedalzheimersdisease
AT barnesjosephine posteriorcerebralatrophyintheabsenceofmedialtemporallobeatrophyinpathologicallyconfirmedalzheimersdisease
AT bartlettjonathanw posteriorcerebralatrophyintheabsenceofmedialtemporallobeatrophyinpathologicallyconfirmedalzheimersdisease
AT ryannatalies posteriorcerebralatrophyintheabsenceofmedialtemporallobeatrophyinpathologicallyconfirmedalzheimersdisease
AT pijnenburgyolandeal posteriorcerebralatrophyintheabsenceofmedialtemporallobeatrophyinpathologicallyconfirmedalzheimersdisease
AT barkhoffrederik posteriorcerebralatrophyintheabsenceofmedialtemporallobeatrophyinpathologicallyconfirmedalzheimersdisease
AT wattjesmikep posteriorcerebralatrophyintheabsenceofmedialtemporallobeatrophyinpathologicallyconfirmedalzheimersdisease
AT scheltensphilip posteriorcerebralatrophyintheabsenceofmedialtemporallobeatrophyinpathologicallyconfirmedalzheimersdisease
AT foxnickc posteriorcerebralatrophyintheabsenceofmedialtemporallobeatrophyinpathologicallyconfirmedalzheimersdisease